Central Trust Company’s iShares iBonds Dec 2020 Term Corporate ETF IBDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-26,615
Closed -$671K 1124
2020
Q3
$671K Sell
26,615
-2,821
-10% -$71.2K 0.03% 301
2020
Q2
$746K Buy
29,436
+17,120
+139% +$433K 0.04% 275
2020
Q1
$310K Hold
12,316
0.02% 362
2019
Q4
$311K Hold
12,316
0.02% 399
2019
Q3
$312K Sell
12,316
-433
-3% -$11K 0.02% 382
2019
Q2
$322K Sell
12,749
-732
-5% -$18.5K 0.02% 389
2019
Q1
$340K Hold
13,481
0.02% 364
2018
Q4
$337K Hold
13,481
0.02% 363
2018
Q3
$337K Buy
13,481
+200
+2% +$5K 0.02% 382
2018
Q2
$333K Buy
13,281
+5,946
+81% +$149K 0.02% 386
2018
Q1
$184K Buy
7,335
+3,260
+80% +$82K 0.01% 474
2017
Q4
$103K Buy
+4,075
New +$104K 0.01% 578

Other funds holding IBDL

Central Trust Company's IBDL Position: Q4 2020 in Review

Central Trust Company sold out of iShares iBonds Dec 2020 Term Corporate ETF (IBDL) in Q4 2020, closing a stake of 26,615 shares — an estimated $671K sold.

Central Trust Company first reported a position in IBDL in Q4 2017 and held it in 12 quarters. The position peaked at $746K in Q2 2020. 1 fund tracked by Wall St. Rank holds IBDL as of Q4 2020.

  • Central Trust Company reported no remaining iShares iBonds Dec 2020 Term Corporate ETF position as of Q4 2020 after selling out during the quarter.
  • Central Trust Company sold 26,615 iShares iBonds Dec 2020 Term Corporate ETF shares in Q4 2020, an estimated $671K.
  • Central Trust Company first reported a position in iShares iBonds Dec 2020 Term Corporate ETF in Q4 2017 and held it in 12 quarters.
  • Central Trust Company's iShares iBonds Dec 2020 Term Corporate ETF position peaked at $746K in Q2 2020.
  • 1 fund tracked by Wall St. Rank held iShares iBonds Dec 2020 Term Corporate ETF as of Q4 2020.

Based on Central Trust Company's 13F filing for Q4 2020, filed 29 Jan 2021.